Literature DB >> 20202003

Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter.

Yoshiaki Kinebuchi1, Naoki Aizawa, Tetsuya Imamura, Osamu Ishizuka, Yasuhiko Igawa, Osamu Nishizawa.   

Abstract

OBJECTIVES: To evaluate the functional and histological recovery by autologous bone-marrow-derived mesenchymal stem cell (BMSC) transplantation into injured rat urethral sphincters.
METHODS: BMSC were harvested from female Sprague-Dawley retired breeder rats for later transplantation. The cells were cultured, and transfected with the green fluorescence protein gene. The urethral sphincters were injured by combined urethrolysis and cardiotoxin injection. One week after injury, the cultured BMSC were injected autologously into the periurethral tissues. Controls included sham-operated rats and injured rats injected with cell-free medium (CFM). Abdominal leak point pressures (LPP) were measured before and after surgery during the following 13 weeks. The urethras were then retrieved for histological evaluation. The presence of green-fluorescence-protein-labeled cells and the regeneration of skeletal muscles, smooth muscles, and peripheral nerves were evaluated by immunohistochemical staining.
RESULTS: LPP was significantly reduced in the injured rats. It increased gradually after transplantation, but there was no significant difference between the BMSC and CFM groups. In the BMSC group, transplanted cells survived and differentiated into striated muscle cells and peripheral nerve cells. The proportions of skeletal muscle cells and peripheral nerves in the urethra were significantly greater in the BMSC group compared to the CFM group.
CONCLUSIONS: Despite a clear trend towards recovery of LPP in BMSC-transplanted urethras, no significant effect was detected. Further study is required for clinical applications for the treatment of stress urinary incontinence.

Entities:  

Mesh:

Year:  2010        PMID: 20202003     DOI: 10.1111/j.1442-2042.2010.02471.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  21 in total

1.  Mesenchymal stem cell therapy in a rat model of birth-trauma injury: functional improvements and biodistribution.

Authors:  Zhina Sadeghi; Justin Isariyawongse; Michael Kavran; Kenan Izgi; Gabriela Marini; Joseph Molter; Firouz Daneshgari; Chris A Flask; Arnold Caplan; Adonis Hijaz
Journal:  Int Urogynecol J       Date:  2015-09-09       Impact factor: 2.894

Review 2.  [Stem cell therapy and tissue engineering in regenerative urology].

Authors:  M Vaegler; B Amend; W Aicher; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2013-12       Impact factor: 0.639

Review 3.  Regenerative medicine based applications to combat stress urinary incontinence.

Authors:  Hatim Thaker; Arun K Sharma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 4.  Stem cell therapy for stress urinary incontinence: a critical review.

Authors:  Ching-Shwun Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2012-01-13       Impact factor: 3.272

Review 5.  Dynamic reciprocity in cell-scaffold interactions.

Authors:  Joshua R Mauney; Rosalyn M Adam
Journal:  Adv Drug Deliv Rev       Date:  2014-10-23       Impact factor: 15.470

6.  Strain-dependent urethral response.

Authors:  Donna J Haworth; Takeya Kitta; Brian Morelli; Douglas W Chew; Naoki Yoshimura; William C de Groat; David A Vorp
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

Review 7.  Stem cell therapy for voiding and erectile dysfunction.

Authors:  Martin Vaegler; Andrew T Lenis; Lisa Daum; Bastian Amend; Arnulf Stenzl; Patricia Toomey; Markus Renninger; Margot S Damaser; Karl-Dietrich Sievert
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

Review 8.  Stem cell therapy for incontinence: where are we now? What is the realistic potential?

Authors:  Charuspong Dissaranan; Michelle A Cruz; Bruna M Couri; Howard B Goldman; Margot S Damaser
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

Review 9.  Development of cellular therapy for the treatment of stress urinary incontinence.

Authors:  Hung-Jen Wang; Yao-Chi Chuang; Michael B Chancellor
Journal:  Int Urogynecol J       Date:  2011-04-20       Impact factor: 2.894

Review 10.  Regenerative medicine and injection therapies in stress urinary incontinence.

Authors:  Christopher J Hillary; Sabiniano Roman; Sheila MacNeil; Wilhelm K Aicher; Arnulf Stenzl; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2020-01-23       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.